(-)-Deprenyl fails to promote axonal regeneration of retinal ganglion cells in vitro and in vivo

Cell and Tissue Research

Volumn 308, Issue 2, 2002, Pages 167-175

  Rosenstiel, Philip ^a   Sievers, Jobst ^a   Lucius, Ralph ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Axonal regeneration, ( ) Deprenyl; Neuroprotection; Rat (Wistar); Retina; Tissue culture

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FREE RADICAL; LINSIDOMINE; SELEGILINE; 3 MORPHOLINO SYDNONIMINE; 3-MORPHOLINO-SYDNONIMINE; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DRUG DERIVATIVE; MOLSIDOMINE; MONOAMINE OXIDASE INHIBITOR; NEUROMODULIN; NEUROPROTECTIVE AGENT; PROTEIN TYROSINE KINASE A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MONOTHERAPY; NERVE FIBER DEGENERATION; NERVE FIBER REGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; MALE; NERVE DEGENERATION; NERVE FIBER; NERVE REGENERATION; NEURITE; OPTIC NERVE; OXIDATIVE STRESS; PROTO ONCOGENE; SPINAL GANGLION; WISTAR RAT;

ANIMAL; AXONS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; FREE RADICALS; GANGLIA, SPINAL; GAP-43 PROTEIN; GENE EXPRESSION REGULATION; GENES, BCL-2; IMMUNOHISTOCHEMISTRY; IN VITRO; MALE; MOLSIDOMINE; MONOAMINE OXIDASE INHIBITORS; NERVE DEGENERATION; NERVE REGENERATION; NEURITES; NEUROPROTECTIVE AGENTS; OPTIC NERVE; OXIDATIVE STRESS; RATS; RATS, WISTAR; RECEPTOR, TRKA; RECEPTOR, TRKB; RETINAL GANGLION CELLS; SELEGILINE; SUPPORT, NON-U.S. GOV'T; ANIMALS;

ANIMALIA; GYMNOMYZA SAMOENSIS;

EID: 0036015676     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-002-0551-x     Document Type: Article

References (46)

1. A qualitative comparison of the reaction of retinal ganglion cells to optic nerve crush in neonatal and adult mice
2. A quantitative comparison of the reaction of retinal ganglion cells to optic nerve crush in neonatal and adult mice
3. L-Deprenyl does not reduce brain damage in global forebrain ischemia in adult gerbils (Meriones unguiculatus)
4. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats
5. Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice overexpressing bcl-2
6. Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment
7. (-)-Deprenyl increases the survival of rat retinal ganglion cells after optic nerve crush
8. Long-term survival of retinal ganglion cells following optic nerve section in adult bcl-2 transgenic mice
9. Optic nerve crush: Axonal responses in wild-type and bcl-2 transgenic mice
10. Neurotrophin-4/5 (NT-4/5) increases adult rat retinal ganglion cell survival and neurite outgrowth in vitro
11. Loss of α-tocopherol upon exposure to nitric oxide or the sydnonimine SIN-1
12. (-)-Deprenyl treatment restores serum insulin-like growth factor-I (IGF-I) levels in aged rats to young rat level
13. Bcl-2 is not required in retinal ganglion cells surviving optic nerve axotomy
14. Long-term effects of pergolide and (-)-deprenyl on 3H-mazindol and 3H-spiperone binding in rat brain
15. Bax antisense oligonucleotides reduce axotomy-induced retinal ganglion cell death in vivo by reduction of Bax protein expression
16. Deprenyl enhances neurite outgrowth in cultured rat spinal ventral horn neurons
17. Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo
18. (-)Deprenyl increases the life span as well as activities of superoxide dismutase and catalase but not of glutathione peroxidase in selective brain regions in Fischer rats
19. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
20. Selegiline treatment after transient global ischemia in gerbils enhances the survival of CA1 pyramidal cells in the hippocampus
21. Metabolism of (-)-deprenyl and PF-(-)-deprenyl in brain after central and peripheral administration
22. Regeneration in the vertebrate central nervous system: Phylogeny, ontogeny, and mechanisms
23. L-deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cells
24. Postnatal retinal ganglion cells in vitro: Protection against reactive oxygen species (ROS)-induced axonal degeneration by cocultured astrocytes
25. YVAD protect post-natal retinal ganglion cells against axotomy-induced but not free radical-induced axonal degeneration in vitro
26. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats
27. Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes
28. Monoamine oxidase inhibition by L-deprenyl depends on both sex and route of administration in the rat
29. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion
30. L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro
31. Neuronal cell death
32. L-deprenyl potentiates cAMP-induced elevation of FGF-2 mRNA levels in rat cortical astrocytes
33. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors
34. Retinal ganglion cell and nonneuronal cell responses to a microcrush lesion of adult rat optic nerve
35. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage
36. DATATOP: A decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl and tocopherol antioxidative therapy of Parkinsonism
37. Fibroblast growth factors promote the survival of adult rat retinal ganglion cells after transection of the optic nerve
38. An inhibitor of neurite outgrowth produced by astrocytes
39. Modulation of gene expression rather than monoamine oxidase inhibition: (-)-Deprenyl-related compounds in controlling neurodegeneration
40. (-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase
41. Apoptosis in neurodegenerative disorders: Potential for therapy by modifying gene transcription
42. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease
43. Diphenylpiperazines enhance regeneration after facial nerve injury
44. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion
45. Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: Time course and modification by (-)-deprenyl